KEYNOTE-630: Phase 3 Study of Adjuvant Pembrolizumab in High-Risk Locally Advanced (LA) Cutaneous Squamous Cell Carcinoma (cSCC)

European Journal of Surgical Oncology(2023)

引用 0|浏览21
暂无评分
关键词
adjuvant pembrolizumab,cutaneous squamous cell carcinoma,squamous cell carcinoma,high-risk
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要